You can be your own worst enemy when it comes to successful investing, so learn from mistakes James Kirby once made.

Telix Pharmaceuticals (ASX:TLX) enters into an asset purchase agreement with antibody engineering company ImaginAb.

In this episode, Fraser Palamara details the major green tick Australian Vanadium (ASX:AVL) received today from the EPA.

ASX slips as rate cut hopes fade, Myer and Premier tank on sales slump, while energy stocks like Woodside rise.

In this episode, host Sarah Hughan recaps the past 12 months for CBL and discusses what it has coming up in 2025.

At CES this year, product launches took a back seat to a bolder narrative for big brands as focus turned to the battle to ...

Magnetic Resources is playing the hits with drilling and studies at its 1.88Moz Lady Julie gold project, with suitors ...

Nvidia’s all-in on AI and robotics with a multi-trillion-dollar vision, plus the GeForce 50 series and Project Digits.

If a big fund manager like AMP has dipped its toe in the Bitcoin water, what should you do in your own portfolio?

Chinese electric vehicles are gaining traction in Australia but overall interest in EVs has dropped, new data suggests.

ASX gold producers lifted the lid this week, with some living up to the hype and others failing to capitalise on record ...

Australia faces a massive green mining challenge, with tailings and precision tech set to revolutionise the game.